Terapia Molecular y Celular

Osvaldo L. Podhajcer - Fundación Instituto Leloir

:
Currently Browsing: Publicaciones

(2019) – González-Pastor R, Ashshi AM, El-Shemi AG, Dmitriev IP, Kashentseva EA, Lu ZH, Goedegebuure SP, Podhajcer OL, Curiel DT

González-Pastor R, Ashshi AM, El-Shemi AG, Dmitriev IP, Kashentseva EA, Lu ZH, Goedegebuure SP, Podhajcer OL, Curiel DT. Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents. J Ovarian Res. 2019 Feb 15;12(1):18
read more

(2018) Iezzi ME, Policastro L, Werbajh S, Podhajcer OL#, Canziani GA#.

Iezzi ME, Policastro L, Werbajh S, Podhajcer OL#, Canziani GA#.  Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment. Front Immunol. 2018 Feb 19;9:273. doi: 10.3389/fimmu.2018.00273.# Shared senior authorship.
read more

(2017) Cafferata EG, Lopez MV, Nuñez FJ, Maenza MAR, Podhajcer OL

Cafferata EG, Lopez MV, Nuñez FJ, Maenza MAR, Podhajcer OL. Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment. Methods Mol Biol. 2017;1651:213-227. doi: 10.1007/978-1-4939-7223-4_16
read more

(2017) Lopez MV, Cafferata EG, Viale DL, Podhajcer OL

Lopez MV, Cafferata EG, Viale DL, Podhajcer OL. Synthetic Tumor-Specific Promoters for Transcriptional Regulation of Viral Replication. Methods Mol Biol. 2017;1651:113-130. doi: 10.1007/978-1-4939-7223-4_9.
read more

(2017) Ana Laura Alfano, Alejandro Nicola Candia, Nicasio Cuneo, Leandro N. Guttlein, Alejandro Soderini, Cecilia Rotondaro, Leonardo Sganga, Osvaldo L. Podhajcer and M. Veronica Lopez.

Ana Laura Alfano, Alejandro Nicola Candia, Nicasio Cuneo, Leandro N. Guttlein, Alejandro Soderini, Cecilia Rotondaro, Leonardo Sganga, Osvaldo L. Podhajcer and M. Veronica Lopez. Oncolytic adenovirus-loaded 1 Menstrual Blood Stem Cells overcome the blockade of viral activity exerted by ovary cancer patients’ ascites. Molecular Therapy Oncolytics. 2017 Jun 16;6:31-44. doi: 10.1016/j.omto.2017.06.002. eCollection 2017 Sep 15.
read more